SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the U.S. Department of Commerce has selected it to verify and distribute economic data onchain, marking a significant step in the adoption of decentralized infrastructure. The community sees this as a major validation of Pyth's role as a trusted data source and anticipates further expansion of its data offerings. Discussions revolve around potential price targets and the impact of institutional adoption on the broader crypto market.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as a Bitcoin-native meme coin built on the Runes protocol, generating excitement for its fair launch and perceived potential to mirror $DOGE.X's success. The community emphasizes its strong connection to the Bitcoin blockchain, arguing it offers enhanced security and utility compared to meme coins on other networks. Discussions also highlight the growing #DOGArmy and anticipation for broader exchange listings.

WorldFinancial

WLFI.X is trending as the community discusses its potential, particularly around its connection to ALTS and the possibility of future token burns. Some investors are analyzing WLFI's underlying asset value and speculating on potential partnerships, while others are wary of its association with Justin Sun and the Trump family. Overall, the conversation is centered on whether WLFI can establish itself in the stablecoin market and deliver on its promises.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is trending as the community discusses potential catalysts, including speculation around a BlackRock ETF filing and its real-world applications. Community members are also highlighting its growing ecosystem with meme coins and new partnerships related to tokenized stocks. Bullish sentiment remains high, with many anticipating a breakout and comparing it to other major cryptocurrencies like XRP.

The mission of the Worldcoin project is to build the world’s largest identity and financial network as a public utility, giving ownership to everyone. A key component of the Worldcoin project is the development of the foundational infrastructure that will be important for a world where AI plays an increasingly large role.  The Worldcoin system revolves around World ID, a privacy-preserving global identity network. World ID enables users to verify their humanness online while maintaining their privacy through zero-knowledge proofs.  Using World ID, individuals will be able to prove that they are a real, unique human to any platform that integrates with the protocol, including to web3 systems, social networking sites, and governmental programs. This will enable fair airdrops or token/NFT sales, provide protection against bots/sybil attacks on social media, and enable the fairer distribution of limited governmental resources. Furthermore, World ID can also enable global democratic processes and novel forms of governance (e.g., via quadratic voting), and it may eventually show a path to AI-funded UBI. The Worldcoin token (WLD), alongside World ID, will let users participate in governing the Worldcoin protocol.   To engage with the Worldcoin protocol, individuals must first download a first wallet app that supports the creation of a World ID. Users visit a physical imaging device called the Orb to get their World ID Orb-verified. Orbs are operated by a network of independent local businesses called Orb Operators. The Orb uses multispectral sensors to verify humanness and uniqueness to issue an Orb-verified World ID, with all images being promptly deleted on-device per default (absent explicit consent to Data Custody). All Orb-verified World IDs holders are entitled to claim recurring grants of free WLD tokens, subject to certain availability restrictions. The WLD token is designed as a utility token with governance properties.

Worldcoin

Worldcoin is trending as the community discusses its potential breakout and recent price movements, with some speculating on targets around $1.00.  Enthusiasm is fueled by mentions of Sam Altman's involvement and perceived real-world use cases, though some express skepticism and concerns about tokenomics and dilution. The launch of new features and partnerships are also being closely watched by investors.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is trending due to an upgrade from UBS to a buy rating, citing long-term growth drivers and potential upside. Community discussions revolve around the stock's disconnect from other semi plays like AMD and NVDA, with some viewing it as an underrated buy-and-hold opportunity. Despite some analyst caution around 2026, the broader sentiment remains optimistic, especially regarding the company's unique position in lithography.

Sapien is an open protocol for sourcing verified human knowledge at scale. Its network of millions of contributors spans more than 100 countries, ranging from doctors and engineers to artists and students. Together they produce high-quality AI training data, validated through Sapien’s onchain Proof of Quality system. This ensures enterprises and AI developers can access trusted, human-in-the-loop data while transforming fragmented online work into a sustainable, reputation-based profession. Incentives across the network are powered by the $SAPIEN token, an ERC-20 asset on Base.

Sapien

Sapien.X is trending as the community anticipates a potential breakout, with some eyeing a move past previous highs. Speculation is fueled by its recent listing on Coinbase and perceived potential in the AI crypto space. However, some traders are wary, citing concerns of a potential scam and volatility.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

CELC is trending after announcing positive Phase 3 trial results for its breast cancer therapy, showing significant reduction in disease progression. The community is buzzing with speculation about FDA approval and potential M&A activity, driving the stock to new highs. Traders are weighing the potential for continued gains against concerns of a possible offering.

NEOS ETF Trust - NEOS Bitcoin High Income ETF

NEOS Bitcoin High Income ETF

NEOS Bitcoin High Income ETF ($BTCI) is trending as investors discuss its attractive distribution yield and strategy of generating monthly income through covered calls on Bitcoin. Community members are weighing reinvesting dividends versus taking profits, while expressing optimism about Bitcoin's long-term potential. The fund's tax efficiency and potential for high returns, even in a range-bound market, are also key talking points.

Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Cameco Corp. is trending as discussions center around potential beneficiaries of new nuclear executive orders and increased demand for nuclear energy to power AI data centers. Community members are analyzing technical indicators, identifying key price levels, and discussing potential price targets. The bullish sentiment is fueled by positive analyst reports, rising uranium prices, and Cameco's strategic positioning in the nuclear energy sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Abeona Therapeutics Inc. (ABEO) were in the spotlight on Tuesday afternoon after it <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.abeonatherapeutics.com/press-releases/detail/303/u-s-fda-approves-zevaskyn-prademagene-zamikeracel">announced</a> that the U.S. Food and Drug Administration (FDA) has approved its gene therapy for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa.Recessive dystrophic epidermolysis bullosa (RDEB) is a genetic skin disease with no known cure caused by a defect in the COL7A1 gene that leaves them unable to produce functioning type VII collagen.Patients with the disease have fragile skin characterized by extensive blistering and severe wounds that often cover more than 30% of the body surface. These wounds are difficult to heal, can remain open for years, and many that do close tend to reopen.Abeona stated that its ZEVASKYN sheet is the only FDA-approved product for treating RDEB wounds with a single application.ZEVASKYN consists of a patient’s skin cells that have been genetically modified to produce functional Type VII collagen. These sheets are then surgically applied to the patient’s wounded areas.Up to 12 credit card-sized sheets can be joined together to cover large areas in a single application, the company said.ZEVASKYN is expected to be available beginning in the third quarter of 2025 through ZEVASKYN Qualified Treatment Centers (QTCs), which are treatment centers located across the U.S. with experience in cell and gene therapy.However, H.C. Wainwright stated on Tuesday that it does not expect ZEVASKYN to have an immediate impact on Krystal Biotech’s Vyjuvek. Vyjuvek is a topical gel aimed at wound healing in patients with dystrophic epidermolysis bullosa.Vyjuvek remains the "differentiated opportunity, particularly with regard to cost, surface area coverage for wound healing and quality of life/convenience," the analyst told investors in a research note, as per TheFly.<a href="https://stocktwits.com/symbol/ABEO">ABEO stock</a> is down by about 16% this year but up by over 44% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/paypal-flags-uncertainty-in-global-macro-environment/chQ6JJNRbLW">PayPal Reports Better-Than-Expected Q1 Earnings But Flags Uncertainty In Global Macro Environment</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a medicine pill is seen in a hand dressed in a medical glove with the U.S. FDA logo in the background. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images) 

Abeona Therapeutics’ Gene Therapy Gets FDA Nod For Treating Rare Genetic Skin Disease

ZEVASKYN is expected to be available beginning in the third quarter of 2025 through ZEVASKYN Qualified Treatment Centers, located across the U.S. with experience in cell and gene therapy.

Equity

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Abeona Therapeutics Inc. - ABEO SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of...

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Abeona Therapeutics Inc. (Abeona or the Company...

The Law Offices of Frank R. Cruz Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Abeona Therapeutics Inc. (Abeona or the Company) (NASDAQ: ABEO) on behalf of investors concerning the Companys possible violations of...

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CLEVELAND, April 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity...

Abeona Therapeutics announces employee inducement grants

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

ABEO
Abeona Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABEO News

ABEO Abeona Therapeutics Inc